Levodopa/Carbidopa Fairmed (Carbidopa, Levodopa)

Levodopa, the active ingredient in Levodopa/Carbidopa Fairmed, is a Levodopa/Carbidopa combination (dopamine precursor and peripheral dopa‑decarboxylase inhibitor) presented as an oral tablet for oral administration. It is used to restore dopaminergic activity in patients with Parkinson's disease and Parkinsonian syndrome, helping to improve motor function and reduce disease‑related symptoms.

GNH USA supplies Levodopa/Carbidopa Fairmed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Levodopa/Carbidopa acts on the dopaminergic pathway to treat movement disorders associated with Parkinsonism. - Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity, and tremor. - Parkinsonian syndrome: alleviates motor dysfunction in secondary or atypical parkinsonism. - Motor fluctuations in Parkinson's disease: reduces off‑time and enhances overall daily functioning.

Levodopa/Carbidopa may cause a range of adverse reactions.

Common Side Effects: - Nausea or vomiting: gastrointestinal upset is frequently reported. - Orthostatic hypotension: sudden drop in blood pressure upon standing. - Dizziness or headache: may occur during dose titration. - Insomnia: sleep disturbances can develop. - Dry mouth: reduced salivation is common. - Mood changes: mild anxiety or agitation may be experienced.

Serious or Rare Side Effects: - Dyskinesia: involuntary movements that can be disabling. - Psychiatric disturbances: hallucinations, confusion, or depression. - Severe hypotension: marked blood pressure fall requiring medical attention. - Cardiac arrhythmias: irregular heart rhythms in susceptible individuals. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Allergic reactions: rash, itching, or swelling indicating hypersensitivity.

Levodopa/Carbidopa requires careful monitoring to minimize risks. - Monitor blood pressure: watch for orthostatic hypotension, especially after dose changes. - Assess psychiatric status: be alert for hallucinations, confusion, or mood swings. - Adjust dose in renal or hepatic impairment: reduced clearance may increase exposure. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Use with caution in cardiovascular disease: underlying heart conditions may be aggravated. - Store at room temperature: keep in the original container, protect from moisture.

Levodopa/Carbidopa can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - High‑dose pyridoxine (vitamin B6): reduces levodopa conversion to dopamine. - Anticholinergic drugs: may mask levodopa side effects and complicate assessment.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive hypotensive effect may require dose adjustment. - SSRIs or SNRIs: potential for serotonin syndrome when combined. - Iron or calcium supplements: decrease levodopa absorption; separate administration by at least two hours.